BOFAS Abstracts Archive

You can search for abstracts by using the search bar below.
Alternatively you can browse through podium and poster presentations by selecting the year and / or type below. You can further refine your search using tags or use the search bar.

Search

RSS Abstracts 476 Expand/Collapse
- RSS 2013 64 Expand/Collapse
  - RSS Poster 24 Expand/Collapse
  - RSS Podium 40 Expand/Collapse
- RSS 2014 36 Expand/Collapse
  - RSS Podium 36 Expand/Collapse
- RSS 2015 49 Expand/Collapse
  - RSS Poster 20 Expand/Collapse
  - RSS Podium 29 Expand/Collapse
- RSS 2016 45 Expand/Collapse
  - RSS Poster 18 Expand/Collapse
  - RSS Podium 27 Expand/Collapse
- RSS 2017 40 Expand/Collapse
  - RSS Poster 15 Expand/Collapse
  - RSS Podium 25 Expand/Collapse
- RSS 2018 47 Expand/Collapse
  - RSS Poster 22 Expand/Collapse
  - RSS Podium 25 Expand/Collapse
- RSS 2019 48 Expand/Collapse
  - RSS Poster 25 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2021 15 Expand/Collapse
  - RSS Poster 10 Expand/Collapse
  - RSS Podium 6 Expand/Collapse
- RSS 2022 46 Expand/Collapse
  - RSS Poster 23 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2023 46 Expand/Collapse
  - RSS Poster 23 Expand/Collapse
  - RSS Podium 23 Expand/Collapse
- RSS 2024 40 Expand/Collapse
  - RSS Poster 18 Expand/Collapse
  - RSS Podium 22 Expand/Collapse

Categories: Abstracts, 2016, Poster

The use of tranexamic acid in foot and ankle surgery

J. Brousil, T. Keith, A. Robinson

¹Addenbrooke's Hospital, Dept of Trauma and Orthopaedics, Cambridge, United Kingdom

²Active Orthopaedic Centre, Orthopaedics, Melbourne, Australia

Introduction: The role of tranexamic acid in foot and ankle surgery has yet to be established. Its use in elective hip and knee arthroplasty and trauma is well documented. The safety and efficacy of the drug in these applications has been proven thanks to large scale high quality feasibility studies. We present a study demonstrating the safe use of tranexamic acid in setting of foot and ankle surgery.

Methods: Over an 18 month period all patients undergoing major foot and ankle reconstructions received an intraoperative dose of tranexamic acid (1g IV infused over 2 minutes). All patients deemed at significant risk of developing a haematoma or wound dehiscence received the drug. These cases were a mix reflected a tertiary UK foot and ankle practice. Case notes were interrogated for patient demographics, thrombosis history, anticoagulation history and wound related complications.

Results: 81 patients were identified as having received 1 g of tranexamic acid intraoperatively. Of these patients the primary pathology in 55% was degenerative (n= 45), 2.5% Diabetes related reconstruction (n=3), 17% were traumatic (n=14) and 23% for deformity (n=19). Five patients (6%) experienced a wound complication, all of which were minor. No patient required a return to theatre and no clinically significant post-operative thrombo-occlusive events were recorded.

Discussion: The use role of tranexamic acid is not yet routine during surgery about the foot and ankle. Its role has been clearly established in trauma and large joint arthroplasty. Similar beneficial effects can be seen in this series of trauma and elective foot and ankle patients. No adverse events occurred.

Conclusion: Tranexamic acid can be safely administered to patients undergoing the full spectrum foot and ankle surgery with minimal risk of adverse events. Further work is required to determine a positive relationship on wound healing complications.

Print

Tags: Peri-operative Care

Click thumbnail below to view poster / thumbnail:

Archive of Abstracts